Toffoli G - Search Results

1

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.

Dreussi E, Pucciarelli S, De Paoli A, Polesel J, Canzonieri V, Agostini M, Friso ML, Belluco C, Buonadonna A, Lonardi S, Zanusso C, De Mattia E, Toffoli G, Cecchin E. Dreussi E, et al. Among authors: toffoli g. Oncotarget. 2016 Apr 12;7(15):19781-93. doi: 10.18632/oncotarget.7757. Oncotarget. 2016. PMID: 26934318 Free PMC article.

2

Pharmacogenetics of irinotecan.

Toffoli G, Cecchin E, Corona G, Boiocchi M. Toffoli G, et al. Curr Med Chem Anticancer Agents. 2003 May;3(3):225-37. doi: 10.2174/1568011033482477. Curr Med Chem Anticancer Agents. 2003. PMID: 12769780 Review.

3

Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases.

Libra M, Sorio R, Buonadonna A, Berretta M, Stefanovski P, Toffoli G, Mazzaglia G, Cordani N, Stivala F, Boiocchi M. Libra M, et al. Among authors: toffoli g. Tumori. 2003 May-Jun;89(3):311-3. doi: 10.1177/030089160308900315. Tumori. 2003. PMID: 12908789

4

Pharmacogenetics of stomach cancer.

Toffoli G, Cecchin E. Toffoli G, et al. Suppl Tumori. 2003 Sep-Oct;2(5):S19-22. Suppl Tumori. 2003. PMID: 12914384 Review.

5

Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase.

Toffoli G, Rossi D, Gaidano G, Cecchin E, Boiocchi M, Carbone A. Toffoli G, et al. Int J Biol Markers. 2003 Jul-Sep;18(3):218-21. doi: 10.1177/172460080301800310. Int J Biol Markers. 2003. PMID: 14535593 Free article.

6

UGT1A1*28 polymorphism in ovarian cancer patients.

Cecchin E, Russo A, Corona G, Campagnutta E, Martella L, Boiocchi M, Toffoli G. Cecchin E, et al. Among authors: toffoli g. Oncol Rep. 2004 Aug;12(2):457-62. Oncol Rep. 2004. PMID: 15254716

7

Lack of association of CYP1 B1*3 polymorphism and ovarian cancer in a Caucasian population.

Cecchin E, Russo A, Campagnutta E, Martella L, Toffoli G. Cecchin E, et al. Among authors: toffoli g. Int J Biol Markers. 2004 Apr-Jun;19(2):160-3. doi: 10.1177/172460080401900212. Int J Biol Markers. 2004. PMID: 15255550 Free article.

8

Pharmacogenomics and stomach cancer.

Toffoli G, Cecchin E. Toffoli G, et al. Pharmacogenomics. 2004 Sep;5(6):627-41. doi: 10.1517/14622416.5.6.627. Pharmacogenomics. 2004. PMID: 15335285 Review.

9

Uridine diphosphoglucuronosyl transferase and methylenetetrahydrofolate reductase polymorphisms as genomic predictors of toxicity and response to irinotecan-, antifolate- and fluoropyrimidine-based chemotherapy.

Toffoli G, Cecchin E. Toffoli G, et al. J Chemother. 2004 Nov;16 Suppl 4:31-5. doi: 10.1179/joc.2004.16.Supplement-1.31. J Chemother. 2004. PMID: 15688606 Review.

10

Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.

Cecchin E, Corona G, Masier S, Biason P, Cattarossi G, Frustaci S, Buonadonna A, Colussi A, Toffoli G. Cecchin E, et al. Among authors: toffoli g. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6901-7. doi: 10.1158/1078-0432.CCR-05-0602. Clin Cancer Res. 2005. PMID: 16203781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters